Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial

BACKGROUND: Current tuberculosis treatments leave most patients with bronchiectasis and fibrosis, permanent conditions that impair lung function and increase all-cause post-TB mortality. Host-directed therapies (HDTs) may reduce lung inflammation and hasten eradication of infection. Biomarkers can a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallis, Robert S., Ginindza, Sibuse, Beattie, Trevor, Arjun, Nishanee, Likoti, Morongwe, Sebe, Modulakgotla, Edward, Vinodh A., Rassool, Mohammed, Ahmed, Khatija, Fielding, Katherine, Ahidjo, Bintou A., Vangu, Mboyo D. T., Churchyard, Gavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815935/
https://www.ncbi.nlm.nih.gov/pubmed/35120127
http://dx.doi.org/10.1371/journal.pone.0252097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815935/
https://www.ncbi.nlm.nih.gov/pubmed/35120127
http://dx.doi.org/10.1371/journal.pone.0252097

Ejemplares similares